Mircera and C-reactive protein increased - a phase IV clinical study of FDA data

Summary:

C-reactive protein increased is reported as a side effect among people who take Mircera (methoxy polyethylene glycol-epoetin beta), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Insulin, and have Hyperphosphataemia.

The phase IV clinical study analyzes which people have C-reactive protein increased when taking Mircera. It is created by eHealthMe based on reports of 10,311 people who have side effects when taking Mircera from the FDA, and is updated regularly.

What is Mircera?

Mircera has active ingredients of methoxy polyethylene glycol-epoetin beta. eHealthMe is studying from 10,321 Mircera users. Check the latest studies of Mircera.

What is C-reactive protein increased?

C-reactive protein increased is found to be associated with 1,568 drugs and 2,281 conditions by eHealthMe. Check the latest studies of C-reactive protein increased.

On Jul, 31, 2026

10,311 people reported to have side effects when taking Mircera.
Among them, 25 people (0.24%) have C-reactive protein increased.

Could Mircera cause C-reactive protein increased?

Among these 25 people:

How long have people been on Mircera when they have C-reactive protein increased? *

What is the gender of people who have C-reactive protein increased when taking Mircera? *

female: 20.83 %
male: 79.17 %

What is the age of people who have C-reactive protein increased when taking Mircera? *

What are other drugs people take besides Mircera? *

What are other side effects people have besides C-reactive protein increased? *

Anaemia (lack of blood): 21 people, 84.00%
Oedema (fluid collection in tissue): 19 people, 76.00%
Dry Skin: 19 people, 76.00%
High Blood Pressure: 19 people, 76.00%
Cardiac Failure: 18 people, 72.00%
Mitral Valve Incompetence (inefficient heart valve): 18 people, 72.00%
Mean Platelet Volume Increased (more than normal average size of platelet cells in blood): 18 people, 72.00%
Dyspnea (difficult or laboured breathing): 18 people, 72.00%
Blood Pressure Systolic Decreased: 18 people, 72.00%
Lymphocyte Count Decreased: 18 people, 72.00%

What are the existing conditions these people have? *

Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 3 people, 12.00%
Chronic Kidney Disease: 2 people, 8.00%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 1 person, 4.00%
Carnitine Deficiency: 1 person, 4.00%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 1 person, 4.00%
Constipation: 1 person, 4.00%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 4.00%
High Blood Pressure: 1 person, 4.00%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 4.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mircera and have C-reactive protein increased?

- Check whether C-reactive protein increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mircera:

Mircera (10,321 reports)

C-reactive protein increased treatments and more:

C-reactive protein increased (52,373 reports)

How severe was C-reactive protein increased and when was it recovered:

C-reactive protein increased in Mircera

Expand to all the drugs that have ingredients of methoxy polyethylene glycol-epoetin beta:

C-reactive protein increased and drugs with ingredients of methoxy polyethylene glycol-epoetin beta

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mircera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with C-reactive protein increased:

C-reactive protein increased (1,568 drugs)

Browse all the conditions that are associated with C-reactive protein increased:

C-reactive protein increased (2,281 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methoxy polyethylene glycol-epoetin beta (the active ingredients of Mircera) and Mircera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.